WO2000071754A8 - Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors - Google Patents
Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factorsInfo
- Publication number
- WO2000071754A8 WO2000071754A8 PCT/US2000/014354 US0014354W WO0071754A8 WO 2000071754 A8 WO2000071754 A8 WO 2000071754A8 US 0014354 W US0014354 W US 0014354W WO 0071754 A8 WO0071754 A8 WO 0071754A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diagnosing
- preventing
- methods
- genetic
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
- C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
- C12N9/003—Dihydrofolate reductase [DHFR] (1.5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00932767A EP1208227A1 (en) | 1999-05-25 | 2000-05-24 | Methods for diagnosing, preventing and treating developmental disorders due to a combination of genetic and environmental factors |
CA002374540A CA2374540A1 (en) | 1999-05-25 | 2000-05-24 | Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors |
PCT/US2000/014354 WO2000071754A1 (en) | 1999-05-25 | 2000-05-24 | Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors |
MXPA01012201A MXPA01012201A (en) | 1999-05-25 | 2000-05-24 | Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors. |
AU50442/00A AU5044200A (en) | 1999-05-25 | 2000-05-24 | Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/318,448 US6210950B1 (en) | 1999-05-25 | 1999-05-25 | Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors |
PCT/US2000/014354 WO2000071754A1 (en) | 1999-05-25 | 2000-05-24 | Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2000071754A1 WO2000071754A1 (en) | 2000-11-30 |
WO2000071754A8 true WO2000071754A8 (en) | 2001-03-08 |
WO2000071754A3 WO2000071754A3 (en) | 2002-03-28 |
Family
ID=23238230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/014354 WO2000071754A1 (en) | 1999-05-25 | 2000-05-24 | Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors |
Country Status (6)
Country | Link |
---|---|
US (1) | US6210950B1 (en) |
EP (1) | EP1208227A1 (en) |
AU (1) | AU5044200A (en) |
CA (1) | CA2374540A1 (en) |
MX (1) | MXPA01012201A (en) |
WO (1) | WO2000071754A1 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6566065B1 (en) | 1994-05-26 | 2003-05-20 | Mcgill University | Method of diagnosing schizophrenia by detecting a mutation in the (MTHFR) gene |
US6570062B1 (en) * | 1997-07-21 | 2003-05-27 | Ohio University | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
US7378506B2 (en) * | 1997-07-21 | 2008-05-27 | Ohio University | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
US6548642B1 (en) * | 1997-07-21 | 2003-04-15 | Ohio University | Synthetic genes for plant gums |
US6639050B1 (en) | 1997-07-21 | 2003-10-28 | Ohio University | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
US6912492B1 (en) * | 1999-05-25 | 2005-06-28 | University Of Medicine & Dentistry Of New Jersey | Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors |
US6632429B1 (en) | 1999-12-17 | 2003-10-14 | Joan M. Fallon | Methods for treating pervasive development disorders |
US20070053895A1 (en) | 2000-08-14 | 2007-03-08 | Fallon Joan M | Method of treating and diagnosing parkinsons disease and related dysautonomic disorders |
US8030002B2 (en) | 2000-11-16 | 2011-10-04 | Curemark Llc | Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions |
US6613763B2 (en) * | 2001-04-20 | 2003-09-02 | Mgi Applied Genomics | Use of molindone to treat oppositional defiant disorder and conduct disorder |
AU2002305384B2 (en) * | 2001-05-04 | 2006-06-01 | University Of Virginia Patent Foundation | Method, apparatus, and computer program product for assessment of attentional impairments |
US7101666B2 (en) * | 2001-08-31 | 2006-09-05 | Centre For Addiction And Mental Health | Involvement of the BDNF gene in mood disorders |
WO2003052093A1 (en) * | 2001-12-19 | 2003-06-26 | Bayer Healthcare Ag | Regulation of human tetrahydrofolate dehydrogenase/cyclohydrolase |
US7087233B2 (en) | 2002-07-05 | 2006-08-08 | Chee-Keung Chung | Antimutagenic effects of Ganoderma lucidum spores |
US20060252120A1 (en) * | 2003-05-09 | 2006-11-09 | Kieliszewski Marcia J | Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
EP1711533B1 (en) * | 2004-01-14 | 2013-12-11 | Ohio University | Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
AU2005223637A1 (en) * | 2004-03-18 | 2005-09-29 | University Of Virginia Patent Foundation | Method, apparatus, and computer program product for stochastic psycho-physiological assessment of attentional impairments |
CA2573918A1 (en) * | 2004-04-19 | 2005-11-24 | Ohio University | Cross-linkable glycoproteins and methods of making the same |
US20060198838A1 (en) * | 2004-09-28 | 2006-09-07 | Fallon Joan M | Combination enzyme for cystic fibrosis |
US7790363B2 (en) * | 2005-02-07 | 2010-09-07 | Abbott Laboratories Inc. | Diagnostic test for vitamin B12 |
WO2007008708A2 (en) * | 2005-07-08 | 2007-01-18 | Ohio University | Methods of predicting hyp-glycosylation sites for proteins expressed and secreted in plant cells, and related methods and products |
US20080058282A1 (en) * | 2005-08-30 | 2008-03-06 | Fallon Joan M | Use of lactulose in the treatment of autism |
US20070116695A1 (en) * | 2005-09-21 | 2007-05-24 | Fallon Joan M | Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders |
US8658163B2 (en) | 2008-03-13 | 2014-02-25 | Curemark Llc | Compositions and use thereof for treating symptoms of preeclampsia |
US8084025B2 (en) | 2008-04-18 | 2011-12-27 | Curemark Llc | Method for the treatment of the symptoms of drug and alcohol addiction |
US9320780B2 (en) * | 2008-06-26 | 2016-04-26 | Curemark Llc | Methods and compositions for the treatment of symptoms of Williams Syndrome |
US20090326832A1 (en) * | 2008-06-27 | 2009-12-31 | Microsoft Corporation | Graphical models for the analysis of genome-wide associations |
WO2010002972A1 (en) * | 2008-07-01 | 2010-01-07 | Curemark, Llc | Methods and compositions for the treatment of symptoms of neurological and mental health disorders |
US10776453B2 (en) * | 2008-08-04 | 2020-09-15 | Galenagen, Llc | Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain |
US20100092447A1 (en) | 2008-10-03 | 2010-04-15 | Fallon Joan M | Methods and compositions for the treatment of symptoms of prion diseases |
GB2480773B (en) | 2009-01-06 | 2013-12-11 | Curelon Llc | Compositions for the treatment of diarrhea caused by virulent E. coli infections |
KR101694930B1 (en) | 2009-01-06 | 2017-01-10 | 큐어론 엘엘씨 | Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces |
US9056050B2 (en) | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
US9511125B2 (en) | 2009-10-21 | 2016-12-06 | Curemark Llc | Methods and compositions for the treatment of influenza |
EP2701733B1 (en) | 2011-04-21 | 2019-04-03 | Curemark, LLC | Compounds for the treatment of neuropsychiatric disorders |
US10350278B2 (en) | 2012-05-30 | 2019-07-16 | Curemark, Llc | Methods of treating Celiac disease |
US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
US20150335262A1 (en) * | 2014-05-22 | 2015-11-26 | New York University | System, method and computer-accessible medium for the probabilistic determination of normal pressure hydrocephalus |
US11541009B2 (en) | 2020-09-10 | 2023-01-03 | Curemark, Llc | Methods of prophylaxis of coronavirus infection and treatment of coronaviruses |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5085983A (en) * | 1988-08-19 | 1992-02-04 | City Of Hope | Detection of human tumor progression and drug resistance |
AU748442B2 (en) * | 1997-07-01 | 2002-06-06 | Cambia | Vertebrate telomerase genes and proteins and uses thereof |
AU768810B2 (en) * | 1998-07-20 | 2004-01-08 | Century Technology, Inc. | Gene sequence variances with utility in determining the treatment of disease |
-
1999
- 1999-05-25 US US09/318,448 patent/US6210950B1/en not_active Expired - Fee Related
-
2000
- 2000-05-24 EP EP00932767A patent/EP1208227A1/en not_active Withdrawn
- 2000-05-24 AU AU50442/00A patent/AU5044200A/en not_active Abandoned
- 2000-05-24 WO PCT/US2000/014354 patent/WO2000071754A1/en not_active Application Discontinuation
- 2000-05-24 CA CA002374540A patent/CA2374540A1/en not_active Abandoned
- 2000-05-24 MX MXPA01012201A patent/MXPA01012201A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US6210950B1 (en) | 2001-04-03 |
EP1208227A1 (en) | 2002-05-29 |
CA2374540A1 (en) | 2000-11-30 |
WO2000071754A1 (en) | 2000-11-30 |
WO2000071754A3 (en) | 2002-03-28 |
MXPA01012201A (en) | 2002-07-02 |
AU5044200A (en) | 2000-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000071754A8 (en) | Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors | |
DE59401483D1 (en) | GRAFTED POLYAMIDOAMINE AND GRAFTED POLYETHYLENIMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AN ADDITIONAL DETERGENT | |
WO1992017152A3 (en) | Method for detecting and treating alzheimer's disease | |
HK1073430A1 (en) | Treatment of central nervous system damage | |
AU2085201A (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
ATE252578T1 (en) | 1,3-OXAZOLINE AND 1,3-THIAZOLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS PESTOPTIC AGENTS | |
WO2001079458A3 (en) | Polypeptides having haloperoxidase activity | |
AU2002366641A1 (en) | Methods for inhibiting ocular processes | |
DE19983529T1 (en) | Zinc stannate buffer layer having photovoltaic components and method for producing the same | |
EP0804548A4 (en) | Patched genes and their use | |
DE69917716D1 (en) | Protein-deamidative enzyme, gene coding therefor, method for the production and use thereof | |
DE69811200D1 (en) | TEMPERED STEEL WITH EXCELLENT PREVENTION OF SECONDARY RECRISTALIZATION DURING CARBONING, METHOD FOR THE PRODUCTION THEREOF, SEMI-PRODUCT FOR PARTS TO BE CARBONED | |
DE59707078D1 (en) | MONOOLEFINIC C 5-MONONITRILE, METHOD FOR THE PRODUCTION AND USE THEREOF | |
WO2001032876A3 (en) | Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions | |
AU2002356998A1 (en) | Genetic markers associated with desirable and undesirable traits in horses, methods of identifying and using such markers | |
DK1900811T3 (en) | Enriched cell populations in the central nervous system | |
DE69410181T2 (en) | ALCOHOLIC AND OLEOPHOBIC, FLUORINE-BASED WETTING AGENTS AND METHOD FOR THE PRODUCTION THEREOF AND THEIR USE | |
ATE474061T1 (en) | METHOD FOR THE ENZYMATIC ENANTIOMER SEPARATION OF 3(R)- AND 3(S)-HYDROXY-1-METHYL-4-(2,4, 6-TRIMETHOXYPHENYL)-1, 2,3,6-TETRAHYDRO-PYRIDINE OR THE CARBOXIC ACID ESTERS | |
DE68917154D1 (en) | C-TERMINUS AMIDATING ENZYME COMPOSITION, METHOD FOR THE PRODUCTION AND USE. | |
MX9600754A (en) | An animal ear tag and method of application. | |
DE69924530D1 (en) | POLYCARBONATE RESIN AND METHOD FOR THE PRODUCTION THEREOF | |
WO2002062205A3 (en) | Methods for diagnosing and treating heart disease | |
WO1997035878A3 (en) | The porcine heart fatty acid-binding protein encoding gene and methods to identify polymorphisms associated with body weight | |
WO2002080755A3 (en) | Kits and methods for assessing oxidative stress | |
DE58905478D1 (en) | GRINDING PIECE FOR CURRENT COLLECTORS AND METHOD FOR THE PRODUCTION THEREOF. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 48/2000 UNDER "PUBLISHED", REPLACE THE EXISTING TEXT BY "WITHOUT INTERNATIONAL SEARCH REPORT AND TO BE REPUBLISHED UPON RECEIPT OF THAT REPORT." AND REPLACE "A1" BY "A2" |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2374540 Country of ref document: CA Kind code of ref document: A Ref document number: 2374540 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/012201 Country of ref document: MX Ref document number: 515740 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 50442/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000932767 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000932767 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000932767 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |